What Happened?
, -based FidoCure Appointed Chase Schwalbach as Chief Product Officer
About the Company
The FidoCure® team is committed to introducing the therapies that have been successfully used to treat humans with cancer into the world of veterinary medicine. Currently, cancer care for dogs lags behind human cancer care by about 20 years. Our goal is to improve the outcome for canine cancer patients. We are the first and only company to offer the information needed to work with your veterinarian on targeted medicines for dogs with cancer.
About the Person
Chase Schwalbach is Chief Product Officer at FidoCure. Previously, Chase held various senior HR leadership roles in the industry.
Info Source
News
Short Profile